Below are Gilead’s Research Scholar Program HIV Awardees and their research titles. As the program values diverse voices and innovative research topics to address areas of unmet medical need, you do not need to duplicate previous research topics in order to be successful for an Award.
Any basic, clinical or public health research proposal that addresses an area of unmet medical need in HIV is welcome.
For other examples of exceptional applications, please visit the NIH’s RO1 sample applications through this helpful resource: https://www.niaid.nih.gov/grants-contracts/sample-applications
2023 Award Recipients
Kay Jin Rayner Tan, PhD
National University of Singapore
Singapore, Singapore
"Co-Creating a Holistic Trauma-Informed Intervention to Address Sexualized Drug Use ('Chemsex') among Gay, Bisexual and other Men who have Sex with Men using Discrete Choice Experiment and Quasi-Experimental Evaluation"
Po-Hsien Kuo, MD
National Taiwan University Hospital Hsinchu Branch
Zhubei City, Taiwan
"Impact of dapagliflozin on the regression of prediabetes in people living with HIV"
Tsz Ho Kwan, PhD
The Chinese University of Hong Kong
Hong Kong, SAR China
"Facilitating routine HIV testing among MSM by a subscription-based HIV self-test distribution model: a stepped wedge randomised controlled trial"
2022 Award Recipients
Guan-Jhou Chen, MD
National Taiwan University College of Medicine
Taipei, Taiwan
"Reducing the risk of viral hepatitis C and other sexually transmitted infections among people living with HIV who are men who have sex with men: efficacy of serious game interventions”
Naoki Kishimoto, PhD
Kumamoto University
Kumamoto, Japan
"Identification of host factors that regulate HIV-1 latent infection under metabolic reprogramming"
2020 Award Recipients
Takayuki Chikata, PhD
Kumamoto University, Joint Research Center for Human Retrovirus Infection
Tokyo, Japan
"Identification and characterization of Immune responses to prevent HIV-1 infection”
Yi-Chia Huang, MD
National Taiwan University Hospital Hsin-Chu Branch
Hsinchu City, Taiwan
"Randomized clinical trial of HBV revaccination among HIV-positive and HIV-negative MSM born in the era of neonatal immunization: investigations of cellular and humoral surrogate markers associated with serological responses”
October 2023, IHQ-UNB-4918